2595 — GenFleet Therapeutics (Shanghai) Cashflow Statement
0.000.00%
Last trade - 00:00- HK$12.41bn
- HK$10.13bn
- CNY130.27m
Annual cashflow statement for GenFleet Therapeutics (Shanghai), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -508 | -678 | -1,794 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 277 | 406 | 1,544 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 11 | 51.3 | 105 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -202 | -206 | -136 |
| Capital Expenditures | -0.594 | -0.236 | -0.107 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 264 | 0.966 | -825 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Change in Net Investments | |||
| Purchase of Investments | |||
| Change in Net Intangibles | |||
| Cash from Investing Activities | 263 | 0.73 | -825 |
| Financing Cash Flow Items | -6.2 | -15.1 | -15.2 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -29.1 | 233 | 1,833 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 36.9 | 29.9 | 835 |